# Effectiveness of Raltegravir-Based Antiretroviral Therapy in HIV-HCV Coinfected Liver Transplant Recipients

> **NCT02995824** · — · COMPLETED · sponsor: **Hospital Clinic of Barcelona** · enrollment: 271 (actual)

## Conditions studied

- Liver Transplantation
- HIV Infections
- Antiretroviral Therapy

## Interventions

- **OTHER:** Raltegravir-based antiretroviral therapy

## Key facts

- **NCT ID:** NCT02995824
- **Lead sponsor:** Hospital Clinic of Barcelona
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2002-01
- **Primary completion:** 2019-12
- **Final completion:** 2019-12-31
- **Target enrollment:** 271 (ACTUAL)
- **Last updated:** 2020-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02995824

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02995824, "Effectiveness of Raltegravir-Based Antiretroviral Therapy in HIV-HCV Coinfected Liver Transplant Recipients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02995824. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*